These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22048026)

  • 21. Characterization of a rat model of Huntington's disease based on targeted expression of mutant huntingtin in the forebrain using adeno-associated viral vectors.
    Gabery S; Sajjad MU; Hult S; Soylu R; Kirik D; Petersén Å
    Eur J Neurosci; 2012 Sep; 36(6):2789-800. PubMed ID: 22731249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease.
    Hermel E; Gafni J; Propp SS; Leavitt BR; Wellington CL; Young JE; Hackam AS; Logvinova AV; Peel AL; Chen SF; Hook V; Singaraja R; Krajewski S; Goldsmith PC; Ellerby HM; Hayden MR; Bredesen DE; Ellerby LM
    Cell Death Differ; 2004 Apr; 11(4):424-38. PubMed ID: 14713958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-124 targets CCNA2 and regulates cell cycle in STHdh(Q111)/Hdh(Q111) cells.
    Das E; Jana NR; Bhattacharyya NP
    Biochem Biophys Res Commun; 2013 Jul; 437(2):217-24. PubMed ID: 23796713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental identification of microRNA targets on the 3' untranslated region of human FMR1 gene.
    Yi YH; Sun XS; Qin JM; Zhao QH; Liao WP; Long YS
    J Neurosci Methods; 2010 Jun; 190(1):34-8. PubMed ID: 20435064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-146a-5p Regulated Cell Proliferation and Apoptosis by Targeting SMAD3 and SMAD4.
    Qiu M; Li T; Wang B; Gong H; Huang T
    Protein Pept Lett; 2020; 27(5):411-418. PubMed ID: 31544687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lentiviral-mediated delivery of mutant huntingtin in the striatum of rats induces a selective neuropathology modulated by polyglutamine repeat size, huntingtin expression levels, and protein length.
    de Almeida LP; Ross CA; Zala D; Aebischer P; Déglon N
    J Neurosci; 2002 May; 22(9):3473-83. PubMed ID: 11978824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Essential sequence of the N-terminal cytoplasmic localization-related domain of huntingtin and its effect on huntingtin aggregates.
    Yan Y; Peng D; Tian J; Chi J; Tan J; Yin X; Pu J; Xia K; Zhang B
    Sci China Life Sci; 2011 Apr; 54(4):342-50. PubMed ID: 21509658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extended polyglutamine repeats trigger a feedback loop involving the mitochondrial complex III, the proteasome and huntingtin aggregates.
    Fukui H; Moraes CT
    Hum Mol Genet; 2007 Apr; 16(7):783-97. PubMed ID: 17356014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progressive phenotype and nuclear accumulation of an amino-terminal cleavage fragment in a transgenic mouse model with inducible expression of full-length mutant huntingtin.
    Tanaka Y; Igarashi S; Nakamura M; Gafni J; Torcassi C; Schilling G; Crippen D; Wood JD; Sawa A; Jenkins NA; Copeland NG; Borchelt DR; Ross CA; Ellerby LM
    Neurobiol Dis; 2006 Feb; 21(2):381-91. PubMed ID: 16150600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Target gene repression mediated by miRNAs miR-181c and miR-9 both of which are down-regulated by amyloid-β.
    Schonrock N; Humphreys DT; Preiss T; Götz J
    J Mol Neurosci; 2012 Feb; 46(2):324-35. PubMed ID: 21720722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adenovirus-mediated silencing of huntingtin expression by shRNA.
    Huang B; Kochanek S
    Hum Gene Ther; 2005 May; 16(5):618-26. PubMed ID: 15916486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Supplemental Treatment for Huntington's Disease with miR-132 that Is Deficient in Huntington's Disease Brain.
    Fukuoka M; Takahashi M; Fujita H; Chiyo T; Popiel HA; Watanabe S; Furuya H; Murata M; Wada K; Okada T; Nagai Y; Hohjoh H
    Mol Ther Nucleic Acids; 2018 Jun; 11():79-90. PubMed ID: 29858092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective degeneration and nuclear localization of mutant huntingtin in the YAC128 mouse model of Huntington disease.
    Van Raamsdonk JM; Murphy Z; Slow EJ; Leavitt BR; Hayden MR
    Hum Mol Genet; 2005 Dec; 14(24):3823-35. PubMed ID: 16278236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of mutant Huntingtin aggregates and toxicity by human myeloid leukemia factors.
    Banerjee M; Datta M; Bhattacharyya NP
    Int J Biochem Cell Biol; 2017 Jan; 82():1-9. PubMed ID: 27840155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The HIV-1 capsid-binding host factor CPSF6 is post-transcriptionally regulated by the cellular microRNA miR-125b.
    Chaudhuri E; Dash S; Balasubramaniam M; Padron A; Holland J; Sowd GA; Villalta F; Engelman AN; Pandhare J; Dash C
    J Biol Chem; 2020 Apr; 295(15):5081-5094. PubMed ID: 32152226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sustained effects of nonallele-specific Huntingtin silencing.
    Drouet V; Perrin V; Hassig R; Dufour N; Auregan G; Alves S; Bonvento G; Brouillet E; Luthi-Carter R; Hantraye P; Déglon N
    Ann Neurol; 2009 Mar; 65(3):276-85. PubMed ID: 19334076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-183 potentially inhibits NF-κB1 expression by directly targeting its 3'-untranslated region.
    Sha F; Wu S; Zhang H; Guo X
    Acta Biochim Biophys Sin (Shanghai); 2014 Nov; 46(11):991-6. PubMed ID: 25274328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global identification of miR-373-regulated genes in breast cancer by quantitative proteomics.
    Yan GR; Xu SH; Tan ZL; Liu L; He QY
    Proteomics; 2011 Mar; 11(5):912-20. PubMed ID: 21271679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease.
    Wellington CL; Ellerby LM; Gutekunst CA; Rogers D; Warby S; Graham RK; Loubser O; van Raamsdonk J; Singaraja R; Yang YZ; Gafni J; Bredesen D; Hersch SM; Leavitt BR; Roy S; Nicholson DW; Hayden MR
    J Neurosci; 2002 Sep; 22(18):7862-72. PubMed ID: 12223539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant Adeno Associated Viral (AAV) vector type 9 delivery of Ex1-Q138-mutant huntingtin in the rat striatum as a short-time model for in vivo studies in drug discovery.
    Ceccarelli I; Fiengo P; Remelli R; Miragliotta V; Rossini L; Biotti I; Cappelli A; Petricca L; La Rosa S; Caricasole A; Pollio G; Scali C
    Neurobiol Dis; 2016 Feb; 86():41-51. PubMed ID: 26626080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.